Anti-PC-7 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the mature N-terminus of human PC-7, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
Q16549
Size
100ug
Cat. #
RP4PC7

In stock

SKU
RP-PC7

Options

As low as: $130.00

Target Overview

Proprotein convertase subtilisin/kexin type 7 (PC-7, PCSK7, UniProt Q16549) is a serine endoprotease belonging to the proprotein convertase family. PC-7 processes precursor proteins by cleavage at paired basic amino acids, recognizing the consensus motif RXXX[KR]R. The enzyme localizes to the trans-Golgi network membrane and likely functions in the constitutive secretory pathway. As a 785-amino acid protein, PC-7 undergoes autocatalytic maturation to generate the active enzyme. Its substrates include pro-growth factors, prohormones, and other precursor proteins requiring endoproteolytic activation. PC-7 shares functional overlap with other proprotein convertases such as furin but exhibits distinct tissue distribution and substrate preferences. The enzyme has been studied in contexts ranging from coagulation factor processing to endocrine function, making it relevant to researchers investigating protein maturation, secretory pathway biology, and protease-mediated regulation of bioactive peptides.

Background

PC-7 belongs to the subtilisin-like proprotein convertase family, which includes seven Ca²⁺-dependent serine proteases (PC1/3, PC2, furin, PC4, PACE4, PC5/6, and PC-7) responsible for proteolytic maturation of secretory and membrane-bound protein precursors. These enzymes cleave at dibasic residue motifs, with PC-7 recognizing RXXX[KR]R sites. Unlike furin, which processes substrates in multiple compartments, PC-7 functions primarily in the trans-Golgi network, suggesting specialized roles in constitutive secretion. The enzyme has been implicated in processing of coagulation factors, neuropeptide precursors, and membrane-bound growth factors, though its precise substrate repertoire remains incompletely characterized compared to more extensively studied family members. Recent work has explored PC-7 function in the context of recombinant therapeutic protein production. Demasi et al (2016) demonstrated that recombinant PC-7, along with other furins, enhanced proteolytic processing of recombinant human coagulation factor VIII B-domain variants, highlighting its utility in biotechnology applications requiring efficient proprotein maturation. The lymphoma proprotein convertase designation reflects early identification in hematopoietic contexts, though PC-7 expression extends to multiple tissue types. Understanding PC-7 substrate specificity and tissue-specific expression patterns continues to inform studies of endocrine signaling, hemostasis, and cellular protein trafficking. Triple Point Biologics offers three PC-7-targeting rabbit polyclonal antibodies raised against the amino-terminal region of the mature protein. These reagents are validated for Western blot, with predicted cross-reactivity to mouse, rat, primate, and canine orthologues based on sequence conservation.

References

  1. Demasi MA et al (2016) Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins. Mol Biotechnol. PubMed · DOI

Additional Specifications

Gene Symbol PCKS7
UniProt ID Q16549
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Amino end mature protein)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 142-192.
Immunogen (P-Domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 470-600.
Immunogen (cytoplasmic domainÂ)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 689-785.
Immunogen (C-terminal cytoplasmic tail)Synthetic peptide corresponding to the C-terminal cytoplasmic tail of human PC-7 (UniProt Q16549).
Alternate Names PC-7, PC7, PCSK7, Proprotein convertase subtilisin/kexin type 7, Proprotein convertase 7, Prohormone convertase 7, Proprotein convertase 8, PC8, hPC8, Lymphoma proprotein convertase, Subtilisin/kexin-like protease PC7

Frequently Asked Questions

What molecular weight should I expect for PC-7 on a Western blot?

PC-7 migrates as a full-length precursor of approximately 87-90 kDa and a mature, autocatalytically processed form around 66-68 kDa. You may observe both species simultaneously depending on cell type and lysis conditions, as PC-7 undergoes activation in the trans-Golgi network. Some tissues or overexpression systems show predominantly the mature form. Under reducing conditions, the prodomain (cleaved during autocatalytic maturation) is typically not retained in the complex, so you will see single bands rather than doublets at lower molecular weights. Always include a positive control lysate known to express PC-7 for band assignment.

Does this PC-7 antibody distinguish between proPC-7 and mature PC-7?

This polyclonal antibody is raised against a region spanning residues that are present in both the zymogen and mature forms of PC-7, so it will detect both proPC-7 (approximately 87-90 kDa) and the autocatalytically processed mature enzyme (approximately 66-68 kDa). If your experimental question requires distinguishing activation state, run samples under reducing conditions and assess the relative intensities of the two bands. Inhibition of furin-like convertases or expression in secretion-deficient cells may shift the ratio toward the proform. The antibody does not selectively immunoprecipitate one form over the other.

What dilution should I start with for Western blot of PC-7?

We recommend starting at 1:1000 dilution for Western blot, which has been validated with this antibody. Because PC-7 is often expressed at moderate to low endogenous levels, you may need to optimize between 1:500 and 1:2000 depending on your sample source and ECL sensitivity. Use 20-50 micrograms of total protein per lane from whole-cell lysates. Membrane-enriched fractions will yield stronger signal since PC-7 localizes to the trans-Golgi network. Overnight incubation at four degrees Celsius often improves signal-to-noise ratio compared to one-hour room-temperature incubations for low-abundance targets like PC-7.

Is this antibody validated for mouse and rat PC-7 or only human?

This antibody has been validated experimentally for human PC-7. Reactivity with mouse and rat is predicted based on sequence homology in the immunogen region but has not been verified in-house. Human and mouse PC-7 share approximately 85 percent identity at the protein level, with strong conservation in the catalytic and P domains. If you are working with rodent samples, we recommend running a pilot blot with a known PC-7-positive tissue such as liver or kidney lysate alongside a knockout or siRNA knockdown control to confirm specific detection before proceeding with experimental samples.

What sample preparation is best for detecting endogenous PC-7 in cell lysates?

PC-7 is a type I transmembrane protein anchored in the trans-Golgi network, so use lysis buffers containing nonionic detergent such as one percent Triton X-100 or 0.5 percent NP-40 in Tris-buffered saline with protease inhibitors. RIPA buffer works well for total lysates. Avoid freeze-thaw cycles that can degrade membrane-associated proteins. Because PC-7 undergoes autocatalytic processing, include a serine protease inhibitor cocktail if you want to preserve the proform, though this is not necessary for standard detection. Membrane-enriched fractions prepared by differential centrifugation will concentrate PC-7 and improve detection compared to whole-cell lysates.

Can I use this PC-7 antibody for immunohistochemistry on paraffin sections?

Triple Point Biologics antibodies are routinely validated for immunohistochemistry, and this PC-7 antibody is suitable for IHC applications. For paraffin-embedded tissues, perform heat-induced epitope retrieval using citrate buffer pH 6.0 or Tris-EDTA pH 9.0; test both to determine which gives better signal in your tissue type. Start with a 1:100 to 1:200 dilution and titrate as needed. PC-7 expression is often strongest in secretory tissues such as liver, intestine, and endocrine glands. Include a no-primary-antibody control and, ideally, a PC-7 knockout or siRNA-treated tissue section to confirm staining specificity.

How should I store the PC-7 antibody and how long is it stable?

Store the antibody at minus twenty degrees Celsius in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100-microgram pack size is suitable for aliquoting into 10-20 microliter volumes depending on your typical Western blot usage at 1:1000 dilution. For short-term use within two to four weeks, the working aliquot can be kept at four degrees Celsius with 0.02 percent sodium azide as preservative if not used for applications incompatible with azide. Properly stored aliquots remain stable for at least twelve months. Centrifuge briefly before use if you observe any precipitate after thawing.

What positive control should I use to validate PC-7 detection?

HeLa, HepG2, and HEK293 cells all express detectable endogenous PC-7 and serve as accessible positive controls for Western blot. Liver and kidney tissue lysates are good choices for tissue-derived controls, as PC-7 is constitutively expressed in these organs. If you have access to a PC-7 overexpression plasmid, transiently transfected HEK293T lysate provides a strong positive control showing both pro- and mature forms. For a negative control, use a lysate from cells treated with PC-7-targeted siRNA for 48-72 hours, or compare signal between wild-type and PC-7 knockout cell lines if available in your system.

Western blot validation for RP-PC7 — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

PC-7: Amino end mature protein — WB validation
WB · Panel 1 PC-7: Amino end mature protein
PC-7: P-Domain — WB validation
WB · Panel 2 PC-7: P-Domain
PC-7: cytoplasmic domain — WB validation
WB · Panel 3 PC-7: cytoplasmic domainÂ
PCSK7: C-terminal cytoplasmic tail — WB validation
WB · Panel 4 PCSK7: C-terminal cytoplasmic tail

Custom validation studies available on request — contact us.

Also known as:

  • PC-7
  • PC7
  • PCSK7
  • Proprotein convertase subtilisin/kexin type 7
  • Proprotein convertase 7
  • Prohormone convertase 7
  • Proprotein convertase 8
  • PC8
  • hPC8
  • Lymphoma proprotein convertase
  • Subtilisin/kexin-like protease PC7
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →